Figure 1
Figure 1. Kaplan-Meier curve of patients with chronic-phase CML with T315I mutation treated with omacetaxine. (A) Progression-free survival and (B) overall survival.

Kaplan-Meier curve of patients with chronic-phase CML with T315I mutation treated with omacetaxine. (A) Progression-free survival and (B) overall survival.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal